• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm.MIB-1标记指数,即Ki-67,是浸润性导管内乳头状黏液性肿瘤的一个指标。
Mol Clin Oncol. 2016 Aug;5(2):317-322. doi: 10.3892/mco.2016.908. Epub 2016 May 20.
2
Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.MIB-1 标记指数(Ki67)与导管内乳头状黏液性肿瘤和普通导管腺癌术后预后的临床病理研究。
Pancreas. 2012 Jan;41(1):114-20. doi: 10.1097/MPA.0b013e318220c1fa.
3
Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas.胰腺导管内乳头状黏液性肿瘤浸润性的预测因素。
Korean J Hepatobiliary Pancreat Surg. 2011 Nov;15(4):237-42. doi: 10.14701/kjhbps.2011.15.4.237. Epub 2011 Dec 15.
4
Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.浸润性混合型导管内乳头状黏液性肿瘤:与浸润性主胰管导管内乳头状黏液性肿瘤相比预后更佳。
Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11.
5
SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.胰腺导管内乳头状黏液性肿瘤壁结节中SLC2A1/GLUT1的表达
Hum Pathol. 2017 Jul;65:71-78. doi: 10.1016/j.humpath.2017.03.008. Epub 2017 Apr 12.
6
Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched-duct and mixed-type intraductal papillary mucinous neoplasm of the pancreas.内镜超声下间隔厚度测量对分支状导管和混合型胰管内乳头状黏液性肿瘤恶性程度的预测价值。
Dig Endosc. 2019 Nov;31(6):672-681. doi: 10.1111/den.13408. Epub 2019 Apr 29.
7
A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.一项关于胰腺分支导管内乳头状黏液性肿瘤手术切除后复发的大型多中心研究。
Minerva Gastroenterol Dietol. 2017 Mar;63(1):50-54. doi: 10.23736/S1121-421X.16.02341-2. Epub 2016 Nov 8.
8
Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions.对比增强内镜超声在检测胰腺导管内乳头状黏液性肿瘤壁结节及做出治疗决策方面的有效性。
Endosc Ultrasound. 2016 Nov-Dec;5(6):377-383. doi: 10.4103/2303-9027.190927.
9
Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.使用对比增强内镜超声对良性和恶性分支导管内乳头状黏液性肿瘤进行鉴别诊断。
World J Gastroenterol. 2015 May 28;21(20):6252-60. doi: 10.3748/wjg.v21.i20.6252.
10
MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.MUC2 表达与混合型胰管内乳头状黏液性肿瘤中高级别异型增生和浸润性癌的发生率。
Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.

引用本文的文献

1
Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer.结直肠癌患者中基质肿瘤浸润淋巴细胞、正常结肠黏膜、癌相关成纤维细胞、临床病理数据及免疫调节分子的相互作用。
Cancer Immunol Immunother. 2021 Sep;70(9):2681-2700. doi: 10.1007/s00262-021-02863-1. Epub 2021 Feb 24.
2
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.胰腺导管内乳头状黏液性肿瘤:对恶性风险分层的当前认识及未来方向
Pancreas. 2018 Mar;47(3):272-279. doi: 10.1097/MPA.0000000000000999.

本文引用的文献

1
The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.主胰管受累型、混合型胰管内乳头状黏液性肿瘤的自然病程:进展的预测参数。
Ann Surg. 2014 Oct;260(4):680-8; discussion 688-90. doi: 10.1097/SLA.0000000000000927.
2
Obesity increases malignant risk in patients with branch-duct intraductal papillary mucinous neoplasm.肥胖增加了分支胰管型胰管内乳头状黏液性肿瘤患者的恶性风险。
Surgery. 2013 Oct;154(4):803-8; discussion 808-9. doi: 10.1016/j.surg.2013.07.011.
3
Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?良性胰腺导管内乳头状黏液性肿瘤切除后是否需要随访?
J Am Coll Surg. 2013 Apr;216(4):657-65; discussion 665-7. doi: 10.1016/j.jamcollsurg.2012.12.026. Epub 2013 Feb 6.
4
Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.目的:定量分析胃肠胰神经内分泌肿瘤的 Ki67 增殖指数:数字图像分析与手动方法的比较。
Am J Surg Pathol. 2012 Dec;36(12):1761-70. doi: 10.1097/PAS.0b013e318263207c.
5
Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.切除胰腺多灶性导管内乳头状黏液性肿瘤患者的临床病理特征。
Surgery. 2012 Sep;152(3 Suppl 1):S74-80. doi: 10.1016/j.surg.2012.05.025. Epub 2012 Jul 6.
6
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.国际共识指南 2012 年:胰腺 IPMN 和 MCN 的管理。
Pancreatology. 2012 May-Jun;12(3):183-97. doi: 10.1016/j.pan.2012.04.004. Epub 2012 Apr 16.
7
Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.胰腺导管内乳头状黏液性肿瘤——一种外科疾病。
Nat Rev Gastroenterol Hepatol. 2012 Mar 6;9(5):253-9. doi: 10.1038/nrgastro.2012.31.
8
Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.MIB-1 标记指数(Ki67)与导管内乳头状黏液性肿瘤和普通导管腺癌术后预后的临床病理研究。
Pancreas. 2012 Jan;41(1):114-20. doi: 10.1097/MPA.0b013e318220c1fa.
9
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.血清碳水化合物抗原 19-9 和癌胚抗原在鉴别胰腺良、恶性导管内乳头状黏液性肿瘤中的作用。
Br J Surg. 2011 Jan;98(1):104-10. doi: 10.1002/bjs.7280. Epub 2010 Oct 14.
10
Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society.具有卵巢型间质的黏液性囊性肿瘤的临床病理特征和预后:日本胰腺学会的多机构研究。
Pancreas. 2011 Jan;40(1):67-71. doi: 10.1097/MPA.0b013e3181f749d3.

MIB-1标记指数,即Ki-67,是浸润性导管内乳头状黏液性肿瘤的一个指标。

MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm.

作者信息

Shimura Tatsuo, Kofunato Yasuhide, Okada Ryo, Yashima Rei, Okada Koji, Araki Kenichiro, Hosouchi Yasuo, Kuwano Hiroyuki, Takenoshita Seiichi

机构信息

Department of Cancer Biology and Electronics, Fukushima Medical University, Fukushima 960-1295, Japan.

Department of Organ Regulatory Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.

出版信息

Mol Clin Oncol. 2016 Aug;5(2):317-322. doi: 10.3892/mco.2016.908. Epub 2016 May 20.

DOI:10.3892/mco.2016.908
PMID:27446570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4950762/
Abstract

Despite strict criteria for the observation of intraductal papillary mucinous neoplasm (IPMN), it remains difficult to distinguish invasive IPMN from non-invasive IPMN. The aim of the present study was to identify an indicator of invasive IPMN. The present study retrospectively evaluated 53 patients (28 with non-invasive and 25 with invasive IPMN) who underwent resection of IPMN, and examined the usefulness of the MIB-1 labeling index as an indicator of invasive IPMN. The MIB-1 labeling indexes in patients with invasive IPMN were significantly higher compared with those with non-invasive IPMN (P<0.001). A receiver operating characteristic curve revealed that the area under the curve was 0.822. These results suggested that a cut-off level for the MIB-1 labeling index should be set to 15.5% to distinguish invasive from non-invasive IPMN. A multivariate analysis using a logistic regression model revealed the MIB-1 labeling index (hazard ratio, 18.692; 95% confidential interval, 4.171-83.760; P<0.001) and the existence of mural nodules (hazard ratio, 6.187, 95% confidential interval, 1.039-36.861; P=0.045) were predictive factors for invasive IPMN. However, no statistically significant differences were observed between patients with a lower MIB-1 labeling index and patients with a higher MIB-1 labeling index (P=0.798). The MIB-1 labeling index must be considered as a candidate for the classification of IPMN.

摘要

尽管对于导管内乳头状黏液性肿瘤(IPMN)的观察有严格标准,但区分浸润性IPMN和非浸润性IPMN仍然困难。本研究的目的是确定浸润性IPMN的一个指标。本研究回顾性评估了53例行IPMN切除术的患者(28例非浸润性IPMN和25例浸润性IPMN),并检验了MIB-1标记指数作为浸润性IPMN指标的有效性。浸润性IPMN患者的MIB-1标记指数显著高于非浸润性IPMN患者(P<0.001)。受试者工作特征曲线显示曲线下面积为0.822。这些结果表明,应将MIB-1标记指数的临界值设定为15.5%,以区分浸润性和非浸润性IPMN。使用逻辑回归模型进行的多变量分析显示,MIB-1标记指数(风险比,18.692;95%置信区间,4.171 - 83.760;P<0.001)和壁结节的存在(风险比,6.187,95%置信区间,1.039 - 36.861;P = 0.045)是浸润性IPMN的预测因素。然而,MIB-1标记指数较低的患者和MIB-1标记指数较高的患者之间未观察到统计学上的显著差异(P = 0.798)。MIB-1标记指数必须被视为IPMN分类的一个候选指标。